The Biotech Growth Trust PLC (BIOG.L)
Stock analysis · LSE · Financial Services · Asset Management
The Biotech Growth Trust PLC (BIOG.L) is a publicly traded company in the Financial Services sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Proprietary Signals
About The Biotech Growth Trust PLC
The Biotech Growth Trust PLC, a closed-ended equity investment vehicle, was originally established by Frostrow Capital LLP and is jointly managed by OrbiMed Capital LLC. Formed on May 20, 1997, and legally based in the United Kingdom, this trust allocates its capital to global public equity markets. Its primary objective is to invest in shares of companies operating within the biotechnology sector, spanning the full range of market capitalizations. The construction of its investment portfolio relies on rigorous fundamental analysis, and its performance is benchmarked against the NASDAQ Biotechnology Index. It was previously identified as Finsbury Emerging Biotechnology Trust PLC.
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap